tradingkey.logo
搜尋

GeneDx Holdings Corp

WGS
添加自選
71.710USD
+3.060+4.46%
收盤 07/01, 16:00美東報價延遲15分鐘
2.13B總市值
虧損本益比TTM

關於 GeneDx Holdings Corp 公司

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

GeneDx Holdings Corp簡介

公司代碼WGS
公司名稱GeneDx Holdings Corp
上市日期Sep 04, 2020
CEOStueland (Katherine A)
員工數量1000
證券類型Ordinary Share
年結日Sep 04
公司地址333 Ludlow Street
城市STAMFORD
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編06902
電話18887291206
網址https://sema4.com/
公司代碼WGS
上市日期Sep 04, 2020
CEOStueland (Katherine A)

GeneDx Holdings Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

常見問題

GeneDx Holdings Corp的前五大股東是誰?

GeneDx Holdings Corp的前五大股東如下:Mr. Joshua Ruch

哪個業務部門對GeneDx Holdings Corp的收入貢獻最大?

在2026Q4,Patients with third party insurance業務部門對GeneDx Holdings Corp的收入貢獻最大,創收345.24M,占總收入的80.75% 。